Value
6.5/10data confidence 100%| Component | Sub-score |
|---|---|
| P/E | 8.2 |
| P/S | 9.3 |
| EV/EBITDA | 7.2 |
| Fwd P/E | 7.8 |
| PEG | 4.1 |
| Analyst target | 4.0 |
- ▸Forward P/E: 15.6x
- ▸PEG: 2.41
MKL · Why this verdict
Why Markel Group (MKL) is rated SELL
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictSELL
Overall score4.4/10
ConfidenceMEDIUM
MacroNEUTRAL
TrendMatrix Research · core thesis
Engine thesis — one sentence
Markel Group's prior earnings beat history and sound Piotroski score are offset by declining revenue, negative free cash flow, and a stock that has already traded through its near-term target — the risk/reward is unfavorable and the setup favors patience or reduction rather than addition.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
Free cash flow is negative — amounting to -58% of net income — which means the business is not generating cash despite reporting positive accounting profits, a red flag that raises questions about earnings quality and the sustainability of capital returns. Quality breakdown | Free cash flow turns positive for 2 consecutive quarters, confirming that the negative reading was a transient deviation rather than a structural feature of the business model. | →Stable |
| CounterInsurance companies routinely show large divergences between reported earnings and free cash flow due to reserve movements and claim timing; a single period of negative free cash flow may not signal genuine cash impairment without context from the reserve cycle. | ||
Three consecutive quarterly beats — including a +45% and a +33% positive surprise — were followed by a miss in the most recent quarter of approximately -11%, creating uncertainty about whether the prior outperformance reflected durable execution or favorable year-ago comparisons that are now fading. The average EPS surprise across all four periods was approximately 17%. Earnings | EPS surprise exceeds 10% in each of the next 2 consecutive quarters, confirming the prior beat pattern has resumed and the recent miss was an anomaly. | →Stable |
| CounterInsurance company earnings are inherently lumpy due to reserve movements and claim timing; the most recent miss may reflect estimate error rather than fundamental deterioration, and the three prior beats were very large, suggesting the business can still outperform. | ||
Revenue declined 17% year-over-year, placing the company at the bottom of its peer group on growth metrics. Sustained top-line contraction in an insurance holding business can signal premium pricing pressure, market share loss, or deliberate risk reduction — each carrying different implications for future earnings. Growth breakdown | Revenue returns to positive year-over-year growth for 2 consecutive quarters, demonstrating that the decline was cyclical rather than structural. | →Stable |
| CounterRevenue contraction in an insurance business may reflect deliberate underwriting discipline — choosing not to write unprofitable policies — which could improve long-term loss ratios even as near-term top-line shrinks. | ||
The stock is currently trading above its near-term technical target, sitting roughly 0.8% above the take-profit level, and the risk/reward geometry is unfavorable — the measured downside exceeds the available upside at the current price, making the setup unattractive for new positions. Price targets | Stock price falls below $1,839 and closes below that level for 10 consecutive trading sessions, restoring a more favorable geometry for potential re-entry. | →Stable |
| CounterA stock that has persistently beaten earnings expectations can trade through analyst targets and remain above them for extended periods; the near-term target may need to be revised upward if fundamentals continue to improve. | ||
Free cash flow is negative — amounting to -58% of net income — which means the business is not generating cash despite reporting positive accounting profits, a red flag that raises questions about earnings quality and the sustainability of capital returns.
→StableQuality breakdown
- Expectation
- Free cash flow turns positive for 2 consecutive quarters, confirming that the negative reading was a transient deviation rather than a structural feature of the business model.
CounterInsurance companies routinely show large divergences between reported earnings and free cash flow due to reserve movements and claim timing; a single period of negative free cash flow may not signal genuine cash impairment without context from the reserve cycle.
Three consecutive quarterly beats — including a +45% and a +33% positive surprise — were followed by a miss in the most recent quarter of approximately -11%, creating uncertainty about whether the prior outperformance reflected durable execution or favorable year-ago comparisons that are now fading. The average EPS surprise across all four periods was approximately 17%.
→StableEarnings
- Expectation
- EPS surprise exceeds 10% in each of the next 2 consecutive quarters, confirming the prior beat pattern has resumed and the recent miss was an anomaly.
CounterInsurance company earnings are inherently lumpy due to reserve movements and claim timing; the most recent miss may reflect estimate error rather than fundamental deterioration, and the three prior beats were very large, suggesting the business can still outperform.
Revenue declined 17% year-over-year, placing the company at the bottom of its peer group on growth metrics. Sustained top-line contraction in an insurance holding business can signal premium pricing pressure, market share loss, or deliberate risk reduction — each carrying different implications for future earnings.
→StableGrowth breakdown
- Expectation
- Revenue returns to positive year-over-year growth for 2 consecutive quarters, demonstrating that the decline was cyclical rather than structural.
CounterRevenue contraction in an insurance business may reflect deliberate underwriting discipline — choosing not to write unprofitable policies — which could improve long-term loss ratios even as near-term top-line shrinks.
The stock is currently trading above its near-term technical target, sitting roughly 0.8% above the take-profit level, and the risk/reward geometry is unfavorable — the measured downside exceeds the available upside at the current price, making the setup unattractive for new positions.
→StablePrice targets
- Expectation
- Stock price falls below $1,839 and closes below that level for 10 consecutive trading sessions, restoring a more favorable geometry for potential re-entry.
CounterA stock that has persistently beaten earnings expectations can trade through analyst targets and remain above them for extended periods; the near-term target may need to be revised upward if fundamentals continue to improve.
Per-dimension breakdown
Quality
4.5/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 3.3 |
| ROA | 1.7 |
| Gross margin | 5.9 |
| Op margin | 0.0 |
| Net margin | 5.5 |
| Current ratio | 9.8 |
| FCF quality | 0.0 |
| Moat | 5.4 |
| Piotroski F | 8.9 |
- ▸Earnings quality RED FLAG: -58% FCF/NI
- ▸No competitive moat
- ▸Strong Piotroski F-Score: 8/9
Growth
0.0/10data confidence 33%| Component | Sub-score |
|---|---|
| Rev growth | 0.0 |
- ▸Declining revenue: -17%
Momentum
5.8/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 2.6 |
| MACD | 10.0 |
| OBV | 10.0 |
| MA position | 6.5 |
| Volume | 0.0 |
- ▸Overbought bear rally (RSI 75)
- ▸Volume accumulation (rising OBV)
- ▸Below 200-MA, MA slope flat
Sentiment
5.3/10data confidence 100%| Component | Sub-score |
|---|---|
| Analyst rating | 5.0 |
| Price target | 5.8 |
| erm sentiment | 5.0 |
Insider
5.0/10data confidence 50%| Component | Sub-score |
|---|---|
| materiality | 5.0 |
| holder change | 5.1 |
- ▸Negligible insider buying — $230,670 (0.001% of mkt cap)
Peer rank
1.8/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 3.3 |
| quality rank | 3.8 |
| growth rank | 0.0 |
Technical
3.3/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 1.1 |
| support resistance | 1.7 |
| 52w position | 7.2 |
Risk (lower is worse)
8.5/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 8.8 |
| days to cover | 7.3 |
| volatility | 8.3 |
| put call | 10.0 |
| implied vol | 8.2 |
| max pain risk | 7.0 |
| beta | 9.0 |
| debt equity | 9.1 |
- ▸Concentration risks: 1 HIGH (10-K Item 1A — sized via position_sizing, validated via buy_confidence)
Catalyst
6.7/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 6.7 |
| earnings timing | 5.0 |
| surprise avg | 10.0 |
- ▸Strong earnings: 3B/1M
How the verdict was assembled
Engine trigger
Multiple concerning factors. Consider reducing position.
Engine technical detail
verdict_path:
L4:PATH_F_SELLPassed (7)
- MOMENTUM:5.8>=5.5
- INSIDER:OK
- 8K:CLEAN
- NEWS_EVENTS:NONE_RECENT
- EARNINGS_PROXIMITY:34d clear
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
- ASYMMETRY:-1.1=NEGATIVE
Warning (1)
- DEATH_CROSS:momentum=5.8>=5.0 recovering
Reward-to-Risk
-1.12
Upside
-8.1%
Downside
7.2%
Sizing output
AVOID
SetupRECOVERY — Death cross but MACD improving, RSI 75
EdgeNO_EDGE — No clear edge identified
SuitabilityMODERATE — Balanced profile
Investment implication
The F-path SELL output reflects an overall score of 4.4 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. The strongest dimension ( Risk (lower is worse) at 8.5) was not enough to lift the adjusted overall above the threshold. Co-occurring failed gates ( ASYMMETRY:-1.1=NEGATIVE) reinforce the read. Current asymmetry R:R is -1.12 — supplementary context, not the trigger for this path.
The strongest dimensions are Risk (lower is worse) at 8.5, Catalyst at 6.7, and Value at 6.5; the weakest are Growth at 0.0, Peer rank at 1.8, and Technical at 3.3. The V9 engine flagged 1 failed gate with 1 warning, producing an asymmetric reward-to-risk of -1.12 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Three consecutive quarterly beats — including a +45% and a +33% positive surprise — were followed by a miss in the most recent quarter of approximately -11%, creating uncertainty about whether the prior outperformance reflected durable execution or favorable year-ago comparisons that are now fading. The average EPS surprise across all four periods was approximately 17%.
Trip ifEPS surprise exceeds 10% in each of the next 2 consecutive quarters.
- P2Free cash flow is negative — amounting to -58% of net income — which means the business is not generating cash despite reporting positive accounting profits, a red flag that raises questions about earnings quality and the sustainability of capital returns.
Trip ifFree cash flow rises above $0 for 2 consecutive quarters.
- P3Revenue declined 17% year-over-year, placing the company at the bottom of its peer group on growth metrics. Sustained top-line contraction in an insurance holding business can signal premium pricing pressure, market share loss, or deliberate risk reduction — each carrying different implications for future earnings.
Trip ifRevenue growth rises above 0% year-over-year for 2 consecutive quarters.
- P4The stock is currently trading above its near-term technical target, sitting roughly 0.8% above the take-profit level, and the risk/reward geometry is unfavorable — the measured downside exceeds the available upside at the current price, making the setup unattractive for new positions.
Trip ifStock price falls below $1,839 and closes below that level for 10 consecutive trading sessions.